During the past decade, Centro Médico Dra. De Salvo conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Médico Dra. De Salvo" are "Bronchiectasis" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Colitis, Ulcerative" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Centro Médico Dra. De Salvo" in a lesser frequency.

Most popular intervention types in "Centro Médico Dra. De Salvo" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Golimumab Dose 1" (1 trials), "Golimumab Dose 2" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Médico Dra. De Salvo" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centro Médico Dra. De Salvo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Médico Dra. De Salvo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Médico Dra. De Salvo, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".